Part A: The purpose of Part A of the study is to look at the electrocardiogram (ECG) effects
due to blood sugar changes after a meal compared to when LY2409021 is also given with a meal.
Part B: The purpose of Part B is to evaluate the effect of LY2409021, when given at a dose
level much higher than what would normally be given, on the electrical activity of the heart
as measured by ECG in relation to placebo and moxifloxacin.